|
Apr 3
|
2 Stocks That Could More Than Double Your Money, According to Wall Street: Are They Buys Now?
|
|
Mar 24
|
3 Mind-Blowing Stocks That Could Turn $1,000 Into $1 Million
|
|
Mar 17
|
US$5.50: That's What Analysts Think Agenus Inc. (NASDAQ:AGEN) Is Worth After Its Latest Results
|
|
Mar 15
|
Agenus Inc. (NASDAQ:AGEN) Q4 2023 Earnings Call Transcript
|
|
Mar 15
|
Analysts Just Shaved Their Agenus Inc. (NASDAQ:AGEN) Forecasts Dramatically
|
|
Mar 14
|
Agenus (AGEN) Q4 2023 Earnings Call Transcript
|
|
Mar 14
|
Agenus Inc (AGEN) Reports Full Year and Q4 2023 Financial Results, Advances in Oncology Pipeline
|
|
Mar 14
|
Agenus Reports Fourth Quarter and Full Year 2023 Results
|
|
Mar 6
|
Agenus Announces Preclinical Data on BMS-986442 (AGEN1777) at AACR 2024
|
|
Mar 5
|
Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
|
Feb 29
|
Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2023 Financial Report
|
|
Feb 26
|
Agenus to Participate in Leerink Partners Global Biopharma Conference
|
|
Jan 22
|
Botensilimab/Balstilimab Breakthrough Data Presented at ASCO-GI Shows Unprecedented Tumor Shrinkage and Robust Biomarker Response in Prevalent Colorectal Cancer Population
|
|
Jan 16
|
Institutional investors may adopt severe steps after Agenus Inc.'s (NASDAQ:AGEN) latest 16% drop adds to a year losses
|
|
Dec 26
|
Merck (MRK) & Daiichi Sankyo's Lung Cancer ADC Gets Priority Tag
|
|
Dec 24
|
2 Small Cap Stocks That Could Go Parabolic in 2024, According to Wall Street
|
|
Dec 21
|
GSK, Hansoh Ink Deal to Develop Lung Cancer ADC Candidate
|
|
Dec 20
|
Botensilimab/Balstilimab Data in Neoadjuvant Colorectal Cancer Selected for ASCO-GI 2024
|
|
Dec 13
|
Blueprint (BPMC) Gets EC Nod for Ayvakit Expanded Use, Stock Up
|
|
Dec 11
|
Agenus to Receive $25 Million Milestone Payment from Bristol Myers Squibb for TIGIT-CD96 Bispecific Program
|